Novartis Institutes for Biomedical Research Senior Developer Salaries in Boston
The average Novartis Institutes for Biomedical Research Senior Developer in Boston earns an estimated $124,025 annually, which includes an estimated base salary of $114,380 with a $9,645 bonus. Novartis Institutes for Biomedical Research's Senior Developer compensation is $13,570 less than the US average for a Senior Developer. Senior Developer salaries at Novartis Institutes for Biomedical Research in Boston can range from $70,000 - $152,000.
In Boston, The Engineering Department at Novartis Institutes for Biomedical Research earns $5,124 more on average than the Product Department.
Last updated 3 years ago.
- $114,380
- avg. base
- $9,645
- avg. bonus
Senior Developer Salaries at Novartis Institutes for Biomedical Research
In Boston, Senior Developers earn $2,266 more than Senior Developers, and $11,319 less than Engineering Managers.
Compensation at Novartis Institutes for Biomedical Research by Department
In Boston, The Engineering Department averages $5,124 more than the Product Department, and $16,790 less than the Legal Department
Senior Developer Compensation by Gender (All Companies)
The average female Senior Developer at companies similar size to Novartis Institutes for Biomedical Research reported making $133,531, while the average male Senior Developer at similar sized companies reported making $149,439.
Senior Developer Compensation by Ethnicity (All Companies)
The average African American/Black Senior Developer at companies similar size to Novartis Institutes for Biomedical Research reported making $160,516, while the average Native American Senior Developer at similar sized companies reported making $127,500.
How Senior Developers at Novartis Institutes for Biomedical Research Rate Their Compensation
The majority of Senior Developers at Novartis Institutes for Biomedical Research believe they're compensated fairly. 100% of Senior Developers at Novartis Institutes for Biomedical Research say they receive annual bonuses, and the majority (43%) are not satisfied with their benefits. See more compensation ratings at Novartis Institutes for Biomedical Research
